MedPath

Investigating the effect of adding Transcranial direct current stimulation (TDCS) to acetaminophen codeine in reducing pain in cancer patients

Phase 3
Recruiting
Conditions
cancer related pain.
Neoplasm related pain (acute) (chronic)
G89.3
Registration Number
IRCT20220719055496N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Any type of cancer
Suffering from moderate to severe pain caused by cancer based on VAS score (5-10)
Informed consent to participate in the study
Absence of depressive disorders, bipolar disorders, or psychotic disorders based on DSM-V diagnostic criteria during examination by a psychiatrist and a psychiatric assistant
No history of epilepsy and other neurological disorders
Absence of pregnancy
No addiction to drugs and opium
Not having implants in the skull or pacemakers or any other prosthetics
No prior exposure to transcranial stimulation treatments

Exclusion Criteria

The final stage of cancer
Lack of informed consent
Aggravation of cancer symptoms and the need for hospitalization during the study
Intensification of pain in such a way that it is necessary to prescribe strong narcotics (morphine, methadone, oxycodone, pethidine)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score of cancer patients according to VAS (Visual Analog Scale). Timepoint: before the intervention and one week, two weeks, three weeks and four weeks after the intervention. Method of measurement: The pain score of the patients is measured by the Visual Analog Scale ruler.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath